Chemical Structure (Yondelis 01)
Yondelis Injection, Powder, Lyophilized, For Solution
Product Images NDC 59676-610
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Yondelis (NDC 59676-610). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Janssen Products, Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Yondelis 02)
This is a description of a clinical trial comparing the efficacy of two drugs, Dacarbazine and Yondelis. The text includes the number of subjects at risk in each group over a period of months. The text does not provide enough information to make any conclusions about the study.*
Principal Display Panel (1 Vial Carton)
This is a description of a drug called Yondelis Y'. It is a trabectedin injection that contains 1mg per vial for intravenous infusion only. The product has been assigned an NDC code of 5967661001 and requires reconstitution before further use. It is a single-dose vial and any unused portion should be discharged as it is cytotoxic. The text has some characters and words that are not recognizable.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
